JP2010529464A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529464A5
JP2010529464A5 JP2010511381A JP2010511381A JP2010529464A5 JP 2010529464 A5 JP2010529464 A5 JP 2010529464A5 JP 2010511381 A JP2010511381 A JP 2010511381A JP 2010511381 A JP2010511381 A JP 2010511381A JP 2010529464 A5 JP2010529464 A5 JP 2010529464A5
Authority
JP
Japan
Prior art keywords
genes
subject
cltb
col4a3bp
sfrs2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010511381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529464A (ja
JP5719591B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066180 external-priority patent/WO2008154423A2/en
Publication of JP2010529464A publication Critical patent/JP2010529464A/ja
Publication of JP2010529464A5 publication Critical patent/JP2010529464A5/ja
Application granted granted Critical
Publication of JP5719591B2 publication Critical patent/JP5719591B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010511381A 2007-06-08 2008-06-06 抗tnf応答性または非応答性を予測するためのバイオマーカー Active JP5719591B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94293707P 2007-06-08 2007-06-08
US60/942,937 2007-06-08
PCT/US2008/066180 WO2008154423A2 (en) 2007-06-08 2008-06-06 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013226708A Division JP2014033676A (ja) 2007-06-08 2013-10-31 抗tnf応答性または非応答性を予測するためのバイオマーカー

Publications (3)

Publication Number Publication Date
JP2010529464A JP2010529464A (ja) 2010-08-26
JP2010529464A5 true JP2010529464A5 (cg-RX-API-DMAC7.html) 2012-07-05
JP5719591B2 JP5719591B2 (ja) 2015-05-20

Family

ID=40130456

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010511381A Active JP5719591B2 (ja) 2007-06-08 2008-06-06 抗tnf応答性または非応答性を予測するためのバイオマーカー
JP2013226708A Withdrawn JP2014033676A (ja) 2007-06-08 2013-10-31 抗tnf応答性または非応答性を予測するためのバイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013226708A Withdrawn JP2014033676A (ja) 2007-06-08 2013-10-31 抗tnf応答性または非応答性を予測するためのバイオマーカー

Country Status (16)

Country Link
US (1) US20100303813A1 (cg-RX-API-DMAC7.html)
EP (2) EP2167687B1 (cg-RX-API-DMAC7.html)
JP (2) JP5719591B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100037590A (cg-RX-API-DMAC7.html)
CN (2) CN103710458A (cg-RX-API-DMAC7.html)
AU (1) AU2008261869B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0812461A2 (cg-RX-API-DMAC7.html)
CA (1) CA2690898A1 (cg-RX-API-DMAC7.html)
EA (1) EA017815B1 (cg-RX-API-DMAC7.html)
IL (2) IL202562A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009013410A (cg-RX-API-DMAC7.html)
NO (1) NO20093488L (cg-RX-API-DMAC7.html)
NZ (1) NZ581742A (cg-RX-API-DMAC7.html)
SG (1) SG182183A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008154423A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200909215B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090235713A1 (en) * 2008-03-24 2009-09-24 Hirotec America, Inc. Magnetically actuated roller head
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP2376091A4 (en) 2008-12-12 2012-08-01 Univ California NEW TARGETS FOR THE TREATMENT OF HYPERCHOLESTERINMIA
JP4883117B2 (ja) * 2009-03-23 2012-02-22 コニカミノルタビジネステクノロジーズ株式会社 画像処理装置の課金装置、それを用いた画像処理装置、画像処理装置の課金装置の制御方法、及び画像処理装置の課金装置の制御プログラム
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック, インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法
SI3409289T1 (sl) 2010-02-26 2020-12-31 Novo Nordisk A/S Stabilni sestavki, ki vsebujejo protitelo
US20130095099A1 (en) * 2010-03-24 2013-04-18 Tc Land Expression Genes and genes combinations predictive of early response or non response of subjects suffering from inflammatory disease to cytokine targeting drugs (cytd)
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
RU2013140975A (ru) 2011-02-28 2015-04-10 Дженентек, Инк. Биологические маркеры и способы прогнозирования восприимчивости к антагонистам в-клеток
EP2812445A2 (en) 2012-02-10 2014-12-17 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
US9031292B2 (en) * 2012-04-19 2015-05-12 Chang Gung University Method for the diagnosis of neurodegenerative disorder by using diffusion kurtosis imaging
EP2861767A4 (en) * 2012-06-15 2016-07-27 Nuclea Biotechnologies Inc PREDICTIVE MARKERS FOR CANCER AND METAL CHANGE SYNDROME
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
ES2524164B1 (es) * 2013-05-03 2015-10-27 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Pronóstico de respuesta al tratamiento con anti-tnfalfa en pacientes de artritis reumatoide
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
US20170306402A1 (en) * 2014-09-12 2017-10-26 Biogen Ma Inc. Systems and methods for characterization of multiple sclerosis
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
US10098168B2 (en) * 2014-12-08 2018-10-09 Apple Inc. Neighbor awareness networking datapath
GB2547406A (en) * 2015-11-20 2017-08-23 Folkersen Lasse Apparatus and methods of using of biomarkers for predicting TNF-inhibitor response
GB201521357D0 (en) * 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
KR20210157427A (ko) 2015-12-03 2021-12-28 리제너론 파마슈티칼스 인코포레이티드 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
CN106520771B (zh) * 2016-12-20 2019-02-12 江苏省人民医院 一种长非编码rna及其在诊断/治疗子痫前期中的应用
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
KR102094802B1 (ko) * 2017-10-24 2020-03-31 고려대학교 산학협력단 소변 대사체 분석을 이용한 베체트병의 진단방법
WO2019178546A1 (en) * 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
CN110141578B (zh) * 2019-06-10 2022-06-14 南通大学 环状RNA circ-Ankib1在制备促进神经再生和修复神经损伤药物中的应用
JP2022541125A (ja) 2019-06-27 2022-09-22 サイファー メディシン コーポレーション 患者を層別化するための分類子の開発
WO2022051245A2 (en) * 2020-09-01 2022-03-10 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
US12379368B2 (en) * 2020-09-11 2025-08-05 Washington University Methods for determining therapeutic responsiveness for inflammatory bowel disease therapy
CN112180082B (zh) * 2020-09-27 2022-03-08 西安交通大学 Tweak在制备红斑狼疮诊断试剂中的应用
RU2749247C1 (ru) * 2020-09-28 2021-06-07 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ прогнозирования эффективности лечения ревматоидного артрита препаратом олокизумаб на основе генотипирования

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499052A (en) 1982-08-30 1985-02-12 Becton, Dickinson And Company Apparatus for distinguishing multiple subpopulations of cells
US4582789A (en) 1984-03-21 1986-04-15 Cetus Corporation Process for labeling nucleic acids using psoralen derivatives
US4563417A (en) 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
SE458968B (sv) 1987-06-16 1989-05-22 Wallac Oy Biospecifikt analysfoerfarande foer flera analyter i vilket ingaar partikelraekning och maerkning med fluorescerande maerksubstanser
DK641487A (da) 1987-12-07 1989-06-08 Gluetech Aps Fremgangsmaade til modificering af polymeroverflader
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
DE69132905T2 (de) 1990-12-06 2002-08-01 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Detektion von Nukleinsäuresequenzen
US5919452A (en) 1991-03-18 1999-07-06 New York University Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
US5656272A (en) 1991-03-18 1997-08-12 New York University Medical Center Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
CA2163032C (en) 1993-06-03 2001-02-06 John Landon Antibody fragments in therapy
US6027880A (en) 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
US5888510A (en) 1993-07-21 1999-03-30 Chugai Seiyaku Kabushiki Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
FR2707882B1 (fr) 1993-07-23 1997-08-01 Immunotech Sa Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US8017121B2 (en) 1994-06-30 2011-09-13 Chugai Seiyaku Kabushika Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
WO1997046313A1 (en) 1996-06-07 1997-12-11 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
US7060667B1 (en) 1998-01-30 2006-06-13 Biogen Idec Ma, Inc. Treatment of follicular lymphomas using inhibitors of the LT pathway
US6197599B1 (en) 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US6410231B1 (en) 1999-02-26 2002-06-25 Incyte Genomics, Inc. SNP detection
EP1204869B1 (en) 1999-08-17 2008-10-22 Luminex Corporation Method for analyzing a number of samples from a variety of sources for a single analyte
JP2003515149A (ja) 1999-11-26 2003-04-22 キュラジェン コーポレイション 核酸プローブアレイ
EP1283722A1 (en) 2000-03-31 2003-02-19 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
WO2002046433A2 (en) * 2000-12-08 2002-06-13 Juan Saus Tnf-inducible promotors and methods for using them
CA2439402A1 (en) 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
EP1379545A2 (de) 2001-04-19 2004-01-14 Gesellschaft für biotechnologische Forschung mbH (GBF) Verfahren zur herstellung stabiler, regenerierbarer antikörper-arrays
US6812341B1 (en) 2001-05-11 2004-11-02 Ambion, Inc. High efficiency mRNA isolation methods and compositions
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20030013208A1 (en) 2001-07-13 2003-01-16 Milagen, Inc. Information enhanced antibody arrays
WO2003062792A2 (en) * 2002-01-22 2003-07-31 Trustees Of The University Of Pennsylvania Methods for determining drug responsiveness
WO2004019277A1 (en) 2002-08-20 2004-03-04 Cyvera Corporation Diffraction grating-based encoded micro-particles for multiplexed experiments
US7252976B2 (en) 2002-08-28 2007-08-07 Board Of Regents The University Of Texas System Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample
JP4463104B2 (ja) 2002-08-30 2010-05-12 財団法人化学及血清療法研究所 ヒト抗ヒトインターロイキン−6抗体及び該抗体フラグメント
AU2003270726A1 (en) 2002-09-12 2004-04-30 Cidra Corporation Diffraction grating-based encoded micro-particles for multiplexed experiments
EP1575707A1 (en) 2002-09-12 2005-09-21 Cyvera Corporation Method and apparatus for aligning elongated microbeads in order to interrogate the same
WO2004025560A1 (en) 2002-09-12 2004-03-25 Cyvera Corporation Assay stick comprising coded microbeads
CA2499037A1 (en) 2002-09-12 2004-03-25 Cyvera Corporation Method and apparatus for labelling using diffraction grating-based encoded optical identification elements
EP1552475A1 (en) 2002-09-12 2005-07-13 Cyvera Corporation Chemical synthesis using diffraction grating-based encoded optical elements
US7092160B2 (en) 2002-09-12 2006-08-15 Illumina, Inc. Method of manufacturing of diffraction grating-based optical identification element
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
JP4685369B2 (ja) * 2004-04-30 2011-05-18 独立行政法人科学技術振興機構 関節リウマチ診断用試薬
US20060008823A1 (en) 2004-05-12 2006-01-12 Kemp Jennifer T DNA profiling and SNP detection utilizing microarrays
TW200630106A (en) * 2004-10-08 2006-09-01 Wyeth Corp Immunotherapy of autoimmune disorders
GB0422417D0 (en) * 2004-10-08 2004-11-10 Ihg Diagnostics Improvements in induced heteroduplex generators
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
PA8672101A1 (es) 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
WO2006122187A2 (en) 2005-05-10 2006-11-16 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CN100338228C (zh) * 2005-06-30 2007-09-19 卫生部北京医院 一种预测2型糖尿病易感性的试剂
CA2620082A1 (en) * 2005-08-24 2007-03-01 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
WO2007038501A2 (en) * 2005-09-27 2007-04-05 The Feinstein Institute For Medical Research Rheumatoid arthritis markers
EP1857559A1 (en) * 2006-05-16 2007-11-21 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for predicting responsiveness to TNF alpha blocking agents
US20080293582A1 (en) * 2006-08-30 2008-11-27 Xilin Li Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 43 Gene Panel
WO2008132176A2 (en) * 2007-04-27 2008-11-06 Universite Catholique De Louvain Method for evaluating the response of an individual to tnf blocking therapy

Similar Documents

Publication Publication Date Title
JP5719591B2 (ja) 抗tnf応答性または非応答性を予測するためのバイオマーカー
WO2014200952A2 (en) Genetic markers of antipsychotic response
JP2007507460A (ja) 炎症性疾患の治療効力と関連している遺伝子多型の使用
JP2005522221A (ja) チロシンキナーゼ阻害剤に対する患者応答性の予測方法
JP2023552199A (ja) コロナウイルス感染症を発症するリスクが高い対象を特定する方法及びその治療法
WO2016057852A1 (en) Markers for hematological cancers
US20130157873A1 (en) Methods of assessing a risk of developing necrotizing meningoencephalitis
CN107849041B (zh) 与对crth2受体拮抗剂的反应有关的遗传标记
WO2012173809A2 (en) Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders
US11499194B2 (en) CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
US20140302013A1 (en) Predicting and diagnosing patients with systemic lupus erythematosus
US20140045717A1 (en) Single Nucleotide Polymorphism Biomarkers for Diagnosing Autism
US20130064819A1 (en) Biomarkers
JP6516128B2 (ja) 抗甲状腺薬誘発性無顆粒球症リスクを判定するための検査方法及び判定用キット
US20170240965A1 (en) Methods for prognosing heart transplant
HK1187650A (en) Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
US20160060699A1 (en) Sle and sle-related disease-associated risk markers and uses thereof
WO2020226936A1 (en) Blood biomarker and genetic markers associated with response to crth2 receptor antagonists
Canzian Identification of polymorphic miRNA-binding sites associated with the risk of multiple myeloma
US20130116139A1 (en) Innate immunity markers of cancer
Butt The genetics of Psoriatic Arthritis
WO2012138566A2 (en) Genetic determinants of prostate and breast cancer risk